« IBM Under Antitrust Investigation - Is It the 1970s All Over Again? | Main | Merger Control in the European Union and the United States: Just the Facts »
March 23, 2010
Inferring the Effects of Vertical Integration from Entry Games: An Analysis of the Generic Pharmaceutical Industry
Posted by D. Daniel Sokol
Kensuke Kubo has written on Inferring the Effects of Vertical Integration from Entry Games: An Analysis of the Generic Pharmaceutical Industry.
ABSTRACT: This paper introduces a novel method for examining the effects of vertical integration. The basic idea is to estimate the parameters of a vertical entry game. By carefully specifying firms' payoff equations and constructing appropriate tests, it is possible to use estimates on rival profit effects to make inferences about the existence of vertical foreclosure. I estimate the vertical entry model using data from the US generic pharmaceutical industry. The estimates indicate that vertical integration is unlikely to generate anticompetitive foreclosure effects. On the other hand, significant efficiency effects are found to arise from vertical integration. I use the parameter estimates to simulate a policy that bans vertically integrated entry. The simulation results suggest that such a ban is counterproductive; it is likely to reduce entry into smaller markets.
March 23, 2010 | Permalink
TrackBack
TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a00d8341bfae553ef01310f7527a1970c
Listed below are links to weblogs that reference Inferring the Effects of Vertical Integration from Entry Games: An Analysis of the Generic Pharmaceutical Industry :
